<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Hyperacusis Guide - Medications & Supplements</title>
  <link rel="stylesheet" href="styles.css">
  <link rel="stylesheet" href="styles.css">
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Montserrat:ital,wght@0,100..900;1,100..900&display=swap" rel="stylesheet">
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.5.0/css/all.min.css">
</head>
<body>
  <header>
    <h1 class="logo">
    Hyperacusis Guide</h1>
    <button id="hamburger">&#9776;</button>
  </header>

  <nav id="sidebar">
    <ul>
      <li><a href="index.html">Precautionary Guide</a></li>
      <li><a href="hyperacusis.html">Hyperacusis & Noxacusis</a></li>
      <li><a href="tinnitus.html">Tinnitus</a></li>
      <li><a href="mem.html">MEM & TTTS</a></li>
      <li><a href="imaging.html">Diagnostic Imaging</a></li>
      <li><a href="medications.html">Medications & Supplements</a></li>
      <li><a href="silverstein.html">Silverstein Procedure</a></li>
      <li><a href="botox.html">Botox</a></li>
      <li><a href="patch.html">Paper Patching</a></li>
      <li><a href="spreadsheets.html">Treatment Spreadsheets</a></li> 
      <li><a href="anatomy.html">Middle Ear Anatomy</a></li>
      <li><a href="social.html">Social & Contact</a></li> 
      <li><a href="about.html">About</a></li>
    </ul>
  </nav>

  <main>
    <article>
  <h1>Medications & Supplements</h1>

  
  <p>Various medications have been tried for hyperacusis and noxacusis, though none have shown consistent or definitive benefit. Some patients report temporary relief from benzodiazepines such as clonazepam or diazepam, which can calm neural hyperexcitability and reduce anxiety associated with sound sensitivity, though their use carries significant risks of dependence and withdrawal. Tricyclic antidepressants such as clomipramine and amitriptyline have been explored for their effects on central pain modulation and tinnitus, but responses vary, and side effects may outweigh benefits in sensitive individuals. Anticonvulsants like gabapentin and pregabalin have also been prescribed for neuropathic-type auditory pain, with mixed results. Ambroxol, a mucolytic drug with emerging sodium channel–blocking and neuroprotective properties, has been experimentally reported by some patients to reduce pain symptoms in noxacusis, though clinical evidence is lacking. Overall, pharmacologic approaches remain largely experimental, and treatment must be individualized, cautious, and combined with environmental stabilization to prevent further auditory injury.</p>
  </article>
  </main>
  
<script src="script.js"></script>
</body>
</html>
